copyright © 2012 Betsy L. Angert. Empathy And Education; BeThink or BeThink.org
Dearest Mitt . . .
I am unsure if we have had the pleasure of an in-person exchange. I too travel in political circles. However, I do not recall. Perhaps we met in the past. I trust I have done business with you and your firm, Bain Capital. Bravo on your successes.
Please allow me to introduce myself by way of this letter. This morning, I caught a glimpse of your Today Show interview with Matt Lauer. I heard you speak of the exaggerated envy now heard on the campaign trail. Oh, my friend Mitt, how I relate. If I might; well stated my man. People do want what they do not have. First Bain, then the White House. Indeed, one Chief Executive position ensured that you were a world power. The other is but a natural transition. Instead of having a seat at the table of global influence, as President of the United States, you, old man, will own the table.
Posted in Economy Economics, Elections
Tagged Bain Capital, bankruptcy, big business, capitalism, Elections 2012, Envy, Equity Firms, Free Enterprise, Free Market, Gains and Losses, Ill Gotten Gains, income inequality, influence, Matt Lauer, Mitt Romney, money, poverty, Presidential Politics, profits, Rick Perry, Venture Capitalism, Vulture Capitalism, Wealth
by Heidi Stevenson 10 January 2011 gaia-health
A sting nailed a company the HHS authorized to oversee human drug trials. The absurdities in the application are belly laugh funny, but in their rush to keep the money coming, they approved it.
The FDA farms out drug and medical device testing. It’s in the hands of the companies hoping to gain approval for their products, but they must first get approval before doing tests on humans. Even here, though, there’s a catch. The FDA doesn’t review the testing plans. That’s done by more for-profit companies, Institutional Review Boards (IRBs). But it gets worse. The IRBs are paid by the companies hoping to gain FDA approval for their products. So, it’s a conflict of interest on top of a conflict of interest.
The First Sting
Congress became suspicious, so they got together with the General Accountability Office (GAO) to set up a sting. They sent out an application for testing of a nonexistent product, Adhesiabloc, by a nonexistent company, Device Med-Systems.
Subtlety is apparently not one of the GAO’s strong suits. Adhesiabloc was described as a gel that would be poured into a patient’s stomach after surgery to collect the bits and pieces left over from the operation. The instructions were to pour more than a liter into the wound.
Posted in Big Pharma, FDA, USDA, Healthcare, Obama and Company
Tagged Conflict of Interest, FDA corruption, health, influence, lobbyists, negligence, Oversight, public safety